Prevymis (letermovir) - Merck (MSD)
Evaluating the relationship between letermovir prophylaxis and medication regimen complexity Index over time in allogeneic hematopoietic stem cell transplant patients. (PubMed, J Oncol Pharm Pract) - May 6, 2025 - "The nonrandomized study design and potential patient differences between groups complicate the interpretation of the findings. Future analyses should aim to account for these differences." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40325932
 
Annie Bui; Anthony Quach; Hailey Hirata; Ila M Saunders; Julie Trinh; Nimish Patel; Shreya Bahl
 
May 6, 2025
 
Prev Next